
|Videos|January 19, 2023
Optimizing Patient Outcomes with JAK Inhibitors
Author(s)Brett King, MD, PhD, Alexandra K. Golant, MD
Brett King, M.D, Ph.D and Alexandra Golant, M.D summarize their thoughts on optimizing treatment outcomes for patients suffering from atopic dermatitis with the JAK inhibitor class.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
The “6-7” Advances for Dermatologists to Look Forward to in 2026
2
Quoin Targets World’s First Approval for Netherton Syndrome Therapy in Saudi Arabia
3
Obagi Launches ALOHA Program to Capture Real-World Insights in Aesthetic Injectables
4
Exploring Type 2 Inflammation and Psoriasis Management at Horizons in Advanced Practice
5























